Embryonic stem cell therapy for paralysis given to first patient in western United States
Wednesday, September 21, 2011 - 14:30
in Health & Medicine
The Stanford University School of Medicine and Santa Clara Valley Medical Center have enrolled the fourth participant in the nations first trial of cells derived from human embryonic stem cells. The phase-1, FDA-approved trial is meant to test the safety of the cells in up to 10 people with recent spinal cord injuries at seven trial sites across the United States.